166 related articles for article (PubMed ID: 38659666)
1. Ceramides: a potential cardiovascular biomarker in young adult childhood cancer survivors?
Broberg O; Weismann CG; Øra I; Wiebe T; Laaksonen R; Liuba P
Eur Heart J Open; 2024 Mar; 4(2):oeae026. PubMed ID: 38659666
[TBL] [Abstract][Full Text] [Related]
2. CERT2 ceramide- and phospholipid-based risk score and major adverse cardiovascular events: A systematic review and meta-analysis.
Papazoglou AS; Stalikas N; Moysidis DV; Otountzidis N; Kartas A; Karagiannidis E; Giannakoulas G; Sianos G
J Clin Lipidol; 2022; 16(3):272-276. PubMed ID: 35219648
[TBL] [Abstract][Full Text] [Related]
3. Prediction of Residual Risk by Ceramide-Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy.
Hilvo M; Wallentin L; Ghukasyan Lakic T; Held C; Kauhanen D; Jylhä A; Lindbäck J; Siegbahn A; Granger CB; Koenig W; Stewart RAH; White H; Laaksonen R;
J Am Heart Assoc; 2020 May; 9(10):e015258. PubMed ID: 32375553
[TBL] [Abstract][Full Text] [Related]
4. Ceramides and Phosphatidylcholines Associate with Cardiovascular Diseases in the Elderly.
Katajamäki TT; Koivula MK; Hilvo M; Lääperi MTA; Salminen MJ; Viljanen AM; Heikkilä ETM; Löppönen MK; Isoaho RE; Kivelä SL; Jylhä A; Viikari L; Irjala KM; Pulkki KJ; Laaksonen RMH
Clin Chem; 2022 Dec; 68(12):1502-1508. PubMed ID: 36308332
[TBL] [Abstract][Full Text] [Related]
5. Comparison of recent ceramide-based coronary risk prediction scores in cardiovascular disease patients.
Leiherer A; Mündlein A; Laaksonen R; Lääperi M; Jylhä A; Fraunberger P; Drexel H
Eur J Prev Cardiol; 2022 May; 29(6):947-956. PubMed ID: 34417607
[TBL] [Abstract][Full Text] [Related]
6. Absolute and relative risk prediction in cardiovascular primary prevention with a modified SCORE chart incorporating ceramide-phospholipid risk score and diabetes mellitus.
Hilvo M; Jylhä A; Lääperi M; Jousilahti P; Laaksonen R
Eur Heart J Open; 2021 Nov; 1(3):oeab010. PubMed ID: 35919880
[TBL] [Abstract][Full Text] [Related]
7. Characterization of Cardiac, Vascular, and Metabolic Changes in Young Childhood Cancer Survivors.
Broberg O; Øra I; Wiebe T; Weismann CG; Liuba P
Front Pediatr; 2021; 9():764679. PubMed ID: 34956978
[No Abstract] [Full Text] [Related]
8. Associations between plasma ceramides and mortality in patients with coronary artery disease.
Li Q; Wang X; Pang J; Zhang Y; Zhang H; Xu Z; Chen Q; Ling W
Atherosclerosis; 2020 Dec; 314():77-83. PubMed ID: 32980131
[TBL] [Abstract][Full Text] [Related]
9. Elevated Plasma Ceramides Are Associated With Antiretroviral Therapy Use and Progression of Carotid Artery Atherosclerosis in HIV Infection.
Zhao W; Wang X; Deik AA; Hanna DB; Wang T; Haberlen SA; Shah SJ; Lazar JM; Hodis HN; Landay AL; Yu B; Gustafson D; Anastos K; Post WS; Clish CB; Kaplan RC; Qi Q
Circulation; 2019 Apr; 139(17):2003-2011. PubMed ID: 30759995
[TBL] [Abstract][Full Text] [Related]
10. Plasma ceramide and phospholipid-based risk score and the risk of cardiovascular death in patients after acute coronary syndrome.
Gencer B; Morrow DA; Braunwald E; Goodrich EL; Hilvo M; Kauhanen D; Sabatine MS; Laaksonen R; O'Donoghue ML
Eur J Prev Cardiol; 2022 May; 29(6):895-902. PubMed ID: 33624052
[TBL] [Abstract][Full Text] [Related]
11. Device-measured physical activity and cardiovascular disease risk in adolescent childhood cancer survivors. A physical activity in childhood cancer survivors (PACCS) study.
Bratteteig M; Anderssen SA; Rueegg CS; Ruud E; Torsvik IK; Kriemler S; Grydeland M
Front Pediatr; 2022; 10():977365. PubMed ID: 36090557
[TBL] [Abstract][Full Text] [Related]
12. Links between ceramides and cardiac function.
Park LK; Garr Barry V; Hong J; Heebink J; Sah R; Peterson LR
Curr Opin Lipidol; 2022 Feb; 33(1):47-56. PubMed ID: 34889803
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients.
Hilvo M; Meikle PJ; Pedersen ER; Tell GS; Dhar I; Brenner H; Schöttker B; Lääperi M; Kauhanen D; Koistinen KM; Jylhä A; Huynh K; Mellett NA; Tonkin AM; Sullivan DR; Simes J; Nestel P; Koenig W; Rothenbacher D; Nygård O; Laaksonen R
Eur Heart J; 2020 Jan; 41(3):371-380. PubMed ID: 31209498
[TBL] [Abstract][Full Text] [Related]
14. The Association Between C24:0/C16:0 Ceramide Ratio and Cardiorespiratory Fitness is Robust to Effect Modifications by Age and Sex.
Zatloukal J; Zylla S; Markus MRP; Ewert R; Gläser S; Völzke H; Albrecht D; Friedrich N; Nauck M; Peterson LR; Jiang X; Schaffer JE; Felix SB; Dörr M; Bahls M; Gross S
Adv Biol (Weinh); 2024 Apr; 8(4):e2300633. PubMed ID: 38342586
[TBL] [Abstract][Full Text] [Related]
15. Dietary Patterns, Ceramide Ratios, and Risk of All-Cause and Cause-Specific Mortality: The Framingham Offspring Study.
Walker ME; Xanthakis V; Peterson LR; Duncan MS; Lee J; Ma J; Bigornia S; Moore LL; Quatromoni PA; Vasan RS; Jacques PF
J Nutr; 2020 Nov; 150(11):2994-3004. PubMed ID: 32939554
[TBL] [Abstract][Full Text] [Related]
16. The Novel Ceramide- and Phosphatidylcholine-Based Risk Score for the Prediction of New-Onset of Hypertension.
Shoghli M; Lokki AI; Lääperi M; Sinisalo J; Lokki ML; Hilvo M; Jylhä A; Tuomilehto J; Laaksonen R
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137595
[TBL] [Abstract][Full Text] [Related]
17. Associations of Adiposity and Diet Quality with Serum Ceramides in Middle-Aged Adults with Cardiovascular Risk Factors.
Drazba MA; Holásková I; Sahyoun NR; Ventura Marra M
J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30999626
[TBL] [Abstract][Full Text] [Related]
18. Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.
Kooijmans EC; Bökenkamp A; Tjahjadi NS; Tettero JM; van Dulmen-den Broeder E; van der Pal HJ; Veening MA
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008944. PubMed ID: 30855726
[TBL] [Abstract][Full Text] [Related]
19. Ceramide Remodeling and Risk of Cardiovascular Events and Mortality.
Peterson LR; Xanthakis V; Duncan MS; Gross S; Friedrich N; Völzke H; Felix SB; Jiang H; Sidhu R; Nauck M; Jiang X; Ory DS; Dörr M; Vasan RS; Schaffer JE
J Am Heart Assoc; 2018 May; 7(10):. PubMed ID: 29728014
[TBL] [Abstract][Full Text] [Related]
20. Plasma Ceramides in Cardiovascular Disease Risk Stratification.
Junqueira DLM; Stach A; Caixeta A; Sallum J; Yasaki E; Tsutsui J; Rizatti E; Rochitte CE; Ching-Jianhong ; Kovalik JP; Krieger JE; Richards AM; Chan MY; Carvalho LP
Arq Bras Cardiol; 2022 Apr; 118(4):768-777. PubMed ID: 35508055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
